Breast Carcinoma by Gene Expression Profile

Breast Carcinoma by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

1,297 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 536
Recruiting: 295
Ph III recruiting: 36
Growth YoY: +3.8%
Industry share: 29%
Top sponsor: Fudan University
Termination share: 45.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (216)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06585969	A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer(DISCORDANT)	withdrawn	Phase 3	0	Danish Breast Cancer Cooperative GroupOTHER	0	Feb 12, 2026	clinicaltrials
NCT05474690	A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer	withdrawn	Phase 3	0	Henan Cancer HospitalOTHER_GOV	1	Feb 26, 2024